Decision of the EEA Joint Committee No 32/2023 of 17 March 2023 amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement [2023/2348]
Date: 2023-03-17
Institutions: EEA Joint Committee
Subjects: European Economic Area, animal disease, application of EU law, disease prevention, health risk, revision of an agreement, vaccine, veterinary legislation, veterinary medicinal product, veterinary medicine




L_202302348EN.000101.fmx.xml












Official Journal of the European Union


EN
Series L













2023/2348


26.10.2023







            DECISION OF THE EEA JOINT COMMITTEE No 32/2023
of 17 March 2023
         
amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement [2023/2348]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2022/140 of 16 November 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to the Union antigen, vaccine and diagnostic reagent banks (1) is to be incorporated into the EEA Agreement.












(2)


This Decision concerns legislation regarding live animals other than fish and aquaculture animals. Legislation concerning these matters shall not apply to Iceland, as specified in paragraph 2 of the Introductory Part of Chapter I of Annex I to the EEA Agreement. This Decision is therefore not to apply to Iceland.












(3)


This Decision concerns legislation regarding veterinary matters. Legislation regarding veterinary matters shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations to Annex I to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.












(4)


Annex I to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
The following point is inserted after point 13u (Commission Delegated Regulation (EU) 2022/139) in Part 1.1 of Chapter I of Annex I to the EEA Agreement:






‘13v.



32022 R 0140: Commission Implementing Regulation (EU) 2022/140 of 16 November 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to the Union antigen, vaccine and diagnostic reagent banks (OJ L 23, 2.2.2022, p. 11).
This act shall not apply to Iceland.’
                        






Article 2
The text of Implementing Regulation (EU) 2022/140 in the Norwegian language, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 18 March 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 17 March 2023.


For the EEA Joint Committee


The President

Nicolas VON LINGEN
            





(1)  
            OJ L 23, 2.2.2022, p. 11.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2023/2348/oj
ISSN 1977-0677 (electronic edition)